跳至主要内容
临床试验/NCT03315598
NCT03315598已完成不适用

Evaluation of an Effectiveness and Safety of the Electroacupuncture in the Management of Intractable Neuropathic Pain: An Open-labeled, Single-arm, Exploratory Pilot Study

Seoul National University1 个研究点 分布在 1 个国家目标入组 22 人开始时间: 2017年5月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
22
试验地点
1
主要终点
Change from baseline Numeric rating scale pain score (0-10) at 8 weeks

研究概览

简要总结

The investigators will evaluate the effectiveness and safety of acupuncture treatment in refractory neuropathic pain patients.

详细描述

The purpose of this study was to evaluate the effectiveness of acupuncture treatment in the patients with the following neuropathic pain related syndrome.

  • Postherpetic neuralgia
  • Failed back surgery syndrome
  • Diabetic neuropathy
  • other peripheral neuropathy

Patients with refractory neuropathic pain who do not respond to conservative treatment for more than 3 months should be included. Acupuncture treatment is maintained for 2 months in oriental medicine hospital. The effect is evaluated through the numeric rating score and the validated questionnaire.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who can adequately write a reportable questionnaire
  • Patients who have been diagnosed with one of the following neuropathic pain disease (postherpetic neuralgia, failed back surgery syndrome, diabetic neuropathy, other peripheral neuropathy)
  • Patients who failed conservative treatment at Seoul National University Hospital for more than 3 months.
  • Patients with NRS 5 points or more
  • Patients with painDETECT score 19 points or more

排除标准

  • Patients with major mental illness
  • Patients with unstable medical conditions
  • Patients who received acupuncture treatment at the site within the past month
  • Patients with bleeding tendency
  • Patients taking immunosuppressive drugs

结局指标

主要结局

Change from baseline Numeric rating scale pain score (0-10) at 8 weeks

时间窗: At 8-week follow-up visit

The Numeric Rating Scale (NRS) is an 11-point scale from 0 to 10 for patient self-reporting of pain. Change from the baseline NRS pain score at 4 weeks will be noted as percentage (%).

Change from baseline Numeric rating scale pain score (0-10) at 4 weeks

时间窗: At 4-week follow-up visit

The Numeric Rating Scale (NRS) is an 11-point scale from 0 to 10 for patient self-reporting of pain. Change from the baseline NRS pain score at 4 weeks will be noted as percentage (%).

次要结局

  • Change from the score of the short-form McGill Pain Questionnaire at 8 weeks(At 8-week follow-up visit)
  • Change from baseline score of Brief Pain Inventory Short Form (BFI-SF) at 8 weeks(At 8-week follow-up visit)
  • 5-pointed patient satisfaction scale(At 8-week follow-up visit)
  • Patients' Global Impression of Change (PGIC) scale(At 8-week follow-up visit)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jeeyoun Moon

Associate professor

Seoul National University

研究点 (1)

Loading locations...

相似试验